This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Trichomoniasis (in males)

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

15-50% of men with Trichomonas are asymptomatic (1).

T. vaginalis produces a low-grade urethritis. The incubation period is 4 days to 3 weeks.

The patient may complain of mild discharge and dysuria. On examination, there may be a slight clear or grey urethral discharge. No meatal inflammation is usually seen. Urethral irritation, frequency, and rarely, balanoposthitis may be present (1).

Investigations include examination of urethral secretions and urine examination - two-glass test (the first glass characteristically contains comma-shaped specks).

Treatment is with metronidazole or tinidazole (1).

  • metronidazole 400 mg twice a day for 5-7 days or 2 g as a single dose if compliance is a problem
    • or
  • tinidazole 2 g as a single dose

Key points (2):

  • oral treatment needed as extravaginal infection common
  • treat partners, and refer to GUM for other STIs

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.